These data, combined with theknowledge acquired from animal models that shows protection against malaria relieson CD8+ T cells detecting malaria-infected hepatocytes[8–10], suggest that the activation ofCD8+ T cells targeting the late liver stage parasite is acritical mechanism of these highly potent whole SPZ vaccines. This evidence concerns the gene CD8A and malaria.